Nucleic Acid Amplification Testing Market

The Nucleic Acid Amplification Testing (NAAT) market comprises molecular techniques used to detect specific genetic material, such as DNA and RNA, in biological samples. The primary customers are central and reference laboratories, as well as hospitals that rely on these tests for high-sensitivity diagnostics. Key market growth is driven by the persistent threat of infectious diseases, the rising prevalence of genetic disorders, expanding applications in oncology, and technological advancements that are making tests faster and more accessible.